HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[High dosage Gd-DPTA-BMA (Gadodiamid) administration in diagnosis and therapeutic monitoring of malignant bone tumors].

AbstractPURPOSE:
To evaluate the efficacy of high-dose Gd-DTPA-BMA (gadodiamide, Omniscan) as a contrast for magnetic resonance imaging of malignant bone tumors and the use of high-dose dynamic studies for predicting the response to pre-operative chemotherapy.
MATERIALS AND METHODS:
Examinations were performed in 22 patients with suspected malignant bone tumor on a 1.5 T system. In 8 cases a follow-up examination was done after preoperative chemotherapy. Static studies included Pd- and T2-weighted spin-echo sequences as well as T1-weighted spin-echo sequences, obtained pre- and post-contrast. Dynamic studies were performed using a FLASH 2D-gradient-echo sequence (TR 40 ms/TE 10 ms, 90 degrees flip angle) every 20 s after intravenous bolus injection of Gd-DTPA-BMA (0.3 mmol/kg body weight). MR images were evaluated qualitatively by visual assessment of conspicuity size, extraosseous delineation and structure of the lesion and quantitatively by measurement of the signal intensities and calculation of the relative increase in signal intensity.
RESULTS:
Qualitative image analysis showed best demonstration of the lesions on contrast-enhanced T1-weighted images. Comparison of T1-weighted pre- and postcontrast spin-echo sequences revealed significantly better assessment of tumor structure after administration of contrast media. After preoperative chemotherapy, all responders showed a markedly stronger reduction in relative increase in signal intensity in dynamic studies compared to nonresponders.
CONCLUSION:
Gd-DTPA-BMA is effective for magnetic resonance imaging of musculoskeletal lesions and improves assessment of the tumor structure. Dynamic studies may help to predict the response to preoperative chemotherapy.
AuthorsM D Häussler, E J Rummeny, C Raufhake, S Blasius, N Lindner, H E Daldrup, P Reimer, P E Peters
JournalDer Radiologe (Radiologe) Vol. 36 Issue 2 Pg. 148-52 (Feb 1996) ISSN: 0033-832X [Print] Germany
Vernacular TitleHochdosierte Anwendung von Gd-DTPA-BMA (Gadodiamid) in der Diagnostik und Therapiebeurteilung maligner Knochentumoren.
PMID8867432 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Contrast Media
  • Organometallic Compounds
  • Pentetic Acid
  • gadodiamide
  • Gadolinium DTPA
Topics
  • Adolescent
  • Adult
  • Aged
  • Bone Neoplasms (diagnosis, pathology, therapy)
  • Bone and Bones (pathology)
  • Child
  • Combined Modality Therapy
  • Contrast Media (administration & dosage)
  • Dose-Response Relationship, Drug
  • Female
  • Gadolinium DTPA
  • Humans
  • Image Enhancement
  • Magnetic Resonance Imaging (methods)
  • Male
  • Middle Aged
  • Organometallic Compounds
  • Pentetic Acid (analogs & derivatives)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: